ATE326218T1 - 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl- pentan-3-ol enthaltendes arzneimittel mit verzögerter wirkstofffreisetzung - Google Patents

1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl- pentan-3-ol enthaltendes arzneimittel mit verzögerter wirkstofffreisetzung

Info

Publication number
ATE326218T1
ATE326218T1 AT03732464T AT03732464T ATE326218T1 AT E326218 T1 ATE326218 T1 AT E326218T1 AT 03732464 T AT03732464 T AT 03732464T AT 03732464 T AT03732464 T AT 03732464T AT E326218 T1 ATE326218 T1 AT E326218T1
Authority
AT
Austria
Prior art keywords
pentan
dimethylamino
methoxy
delayed
phenyl
Prior art date
Application number
AT03732464T
Other languages
German (de)
English (en)
Inventor
Johannes Bartholomaeus
Iris Ziegler
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Application granted granted Critical
Publication of ATE326218T1 publication Critical patent/ATE326218T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT03732464T 2002-05-29 2003-05-26 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl- pentan-3-ol enthaltendes arzneimittel mit verzögerter wirkstofffreisetzung ATE326218T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10224108A DE10224108A1 (de) 2002-05-29 2002-05-29 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol enthaltendes Arzneimiitel mit verzögerter Wirkstofffreisetzung

Publications (1)

Publication Number Publication Date
ATE326218T1 true ATE326218T1 (de) 2006-06-15

Family

ID=29557413

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03732464T ATE326218T1 (de) 2002-05-29 2003-05-26 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl- pentan-3-ol enthaltendes arzneimittel mit verzögerter wirkstofffreisetzung

Country Status (14)

Country Link
EP (1) EP1507519B1 (enExample)
JP (1) JP5459818B2 (enExample)
AR (1) AR039900A1 (enExample)
AT (1) ATE326218T1 (enExample)
AU (1) AU2003238397A1 (enExample)
CA (1) CA2488220C (enExample)
DE (2) DE10224108A1 (enExample)
DK (1) DK1507519T3 (enExample)
ES (1) ES2263976T3 (enExample)
MY (1) MY134311A (enExample)
PE (1) PE20040529A1 (enExample)
PL (1) PL218397B1 (enExample)
PT (1) PT1507519E (enExample)
WO (1) WO2003099267A1 (enExample)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US5032406A (en) * 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
US5582837A (en) * 1992-03-25 1996-12-10 Depomed, Inc. Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
JPH06172161A (ja) * 1992-12-10 1994-06-21 Shin Etsu Chem Co Ltd 徐放性錠剤
DE4329794C2 (de) * 1993-09-03 1997-09-18 Gruenenthal Gmbh Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
JPH1017497A (ja) * 1996-07-02 1998-01-20 Takeda Chem Ind Ltd 徐放性製剤およびその製造方法
DE10059412A1 (de) * 2000-11-30 2002-06-13 Gruenenthal Gmbh Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie der Harninkontinenz
DE10146275A1 (de) * 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz

Also Published As

Publication number Publication date
DE50303372D1 (de) 2006-06-22
EP1507519A1 (de) 2005-02-23
CA2488220A1 (en) 2003-12-04
JP5459818B2 (ja) 2014-04-02
DK1507519T3 (da) 2006-08-28
AR039900A1 (es) 2005-03-09
WO2003099267A1 (de) 2003-12-04
PT1507519E (pt) 2006-08-31
PE20040529A1 (es) 2004-08-24
CA2488220C (en) 2011-02-01
EP1507519B1 (de) 2006-05-17
JP2005534640A (ja) 2005-11-17
AU2003238397A1 (en) 2003-12-12
MY134311A (en) 2007-12-31
PL218397B1 (pl) 2014-11-28
DE10224108A1 (de) 2004-01-29
PL374186A1 (en) 2005-10-03
ES2263976T3 (es) 2006-12-16

Similar Documents

Publication Publication Date Title
ATE303802T1 (de) 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phen l enthaltendes arzneimittel mit verzögerter wirkstofffreisetzung
NO20033143D0 (no) Farmasoytisk preparat
PT1207867E (pt) Formas de administracao farmaceuticas orais retardadas contendo tramadol
ATE456368T1 (de) Reboxetin enthaltende tablette mit verzögerter wirkstoffabgabe
KR20050009999A (ko) 약제학적 제제
DK1441713T3 (da) Tamsulosin-tabletter med modificeret frigivelse
AU2003244650A8 (en) Medicinal compounds
GB0204719D0 (en) Medicinal compounds
GB0220730D0 (en) Medicinal compounds
ATE481966T1 (de) Polyacrylfilm formende zubereitungen
NO20033205L (no) Terapeutiske kromanforbindelser
DE60203537D1 (de) 5ht1-rezeptoragonist enthaltendes arzneimittel
DE50209245D1 (de) Neuroprotektives medikament
ATE389392T1 (de) Paracetamol enthaltende tablette
ATE434435T1 (de) Pharmazeutische zubereitungen enthaltend modafinil
ATE326218T1 (de) 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl- pentan-3-ol enthaltendes arzneimittel mit verzögerter wirkstofffreisetzung
IS7581A (is) Lyfjasamsetning
NO20054157D0 (no) Formuleringer av venlafaksin med forsinket frigjoring
ATA8202001A (de) Medikamentenapplikator
DE50301052D1 (de) Arzneimittel enthaltend betamimetika und ein neues anticholinergikum
FI20012242A0 (fi) Uudet farmaseuttiset yhdisteet
DK1496890T3 (da) Substituerede beta-aminoalkoholer som lægemiddel
NO20044424L (no) Fremgangsmate for fremstilling av sertindol
SE0200008D0 (sv) New pharmaceutically compounds
SE0102823D0 (sv) New drug

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee